Digital healthcare startup Indream Healthcare announced that it has been selected for TIPS, a technology startup support program run by the Ministry of SMEs and Startups. This selection was made following a recommendation from Reventures, the operator of TIPS.
TIPS is a technology startup incubation program where the government matches research and development (R&D) funding with promising startups selected by private investors. Building on this program, Indream Healthcare is moving beyond its existing multi-drug management solution to develop a pharmacogenomics (PGx)-based real-time precision medicine clinical decision support system (CDSS).
In the medical field, the difficulty of comprehensively managing medications prescribed by patients from multiple hospitals and the difficulty of reflecting individual genetic differences in drug responses have been raised, increasing the risk of adverse effects. In Korea, 46% of patients aged 65 and older are taking five or more medications, and approximately half of all patient safety incidents are known to be drug-related.
To address these issues, Indream Healthcare is advancing its core technologies, including ▲Pharmaco-Atlas, a data asset platform that standardizes PGx test results; ▲SynapseRx Engine, an AI engine that predicts risk by combining personal genetic information and clinical data; and ▲Precision Navigator, an interface that intuitively presents analysis results to medical staff and patients.
Additionally, the company has commercialized "MediSupport," a physician solution that integrates with hospital electronic medical records (EMRs), and "MyChart," a patient app, and completed validation trials at Jeju National University Hospital and other institutions. With this TIPS selection, the company plans to expand beyond simple medication management to a precision medicine platform that supports personalized prescriptions based on genome analysis.
CEO Kang Byung-joo stated, “We will implement a real-time precision medical system that reflects the genetic characteristics of each patient,” and “We will grow into a global standard platform through the advancement of TIPS-based technology.”
- See more related articles
You must be logged in to post a comment.